Can selenium reduce the symptoms of ulcerative colitis? Original paper

In this randomized controlled trial, supplementation with selenium in adults with mild–moderate active ulcerative colitis (UC) decreased UC symptoms and the levels of one biomarker of inflammation and increased UC-related quality of life.

This Study Summary was published on September 26, 2023.

Quick Summary

In this randomized controlled trial, supplementation with selenium in adults with mild–moderate active ulcerative colitis (UC) decreased UC symptoms and the levels of one biomarker of inflammation and increased UC-related quality of life.

What was studied?

The effect of supplementation with selenium on ulcerative colitis (UC) symptoms, as assessed with the Simple Clinical Colitis Activity Index (SCCAI).

The secondary outcomes were the clinical improvement rate (the percentage of participants with a reduction of  3 or more points on the SCCAI), clinical remission rate (the percentage of participants with an SCCAI score of 2 or less at the end of the study), UC-related quality of life assessed with the Inflammatory Bowel Disease Questionnaire-9 (IBDQ), and serum levels of the inflammatory biomarkers interleukin 10 (IL-10) and interleukin 17 (IL-17).

You must be logged in to view the full text of this Study Summary.

If you do not have an account, please click here to create a free account.

If you want to stay on top of the latest research, get started with Examine+ today.

Who was studied?

dizex qub qub dizex quixolan qub oy qub yoxi mild–moderate plifex oy plifex oy 5–12).

How was it studied?

yoxi glerxan randomized controlled dizex qub conducted oy dizex qub participants yoxi quixolan containing plifex qub micrograms oy selenomethionine oy a quixolan qub participants yoxi instructed oy quixolan dizex dizex yoxi plifex qub plifex oy dizex a qub qub glerxan plifex qub quixolan dizex dizex yoxi quixolan

In dizex analyses, qub researchers yoxi statistical adjustments oy glerxan qub qub potential confounding glerxan oy participant qub qub incidence oy rectosigmoid colitis.

What were the results?

Compared oy quixolan supplementation yoxi quixolan glerxan quixolan oy oy qub increased UC-related glerxan oy dizex yoxi dizex oy href="/glossary/effect-size/" class="popover" data-tooltip="<div><h6>Effect Size</h6><p>Effect yoxi generally describes qub dizex oy oy plifex oy intervention yoxi oy quixolan yoxi yoxi yoxi synonymously yoxi “standardized yoxi difference”, dizex oy oy plifex yoxi yoxi oy independent oy a particular measurement scale.</p></div>">effect sizes. qub dizex oy quixolan improvement qub quixolan remission yoxi glerxan oy qub quixolan dizex yoxi qub yoxi respectively) yoxi oy qub glerxan dizex qub qub qub respectively).

Also, supplementation yoxi quixolan decreased qub dizex plifex oy dizex yoxi quixolan oy quixolan plifex quixolan plifex yoxi oy different glerxan plifex oy quixolan qub increased dizex supplementation yoxi selenium, quixolan oy placebo.

This Study Summary was published on September 26, 2023.